About Us? Indchemie health specialities pvt. Ltd? has been in the ethical pharma business for more than two decades now, with leadership in few of the segments. It has a strong back up of in-house manufacturing facility & has four pharmaceuticals manufacturing units (two at daman, 3rd at baddi, himachal pradesh & 4th at sikkim) in india. all four units are approved by who based on current gmp guidelines.
out of four units, one of the manufacturing units is totally dedicated to soft gelatin capsules formulation. In march 2006 it was audited & in june 2006 the same has been approved by tga, australia. The next level of achievement would be usfda & mhra, uk approvals and the technical team has geared up for these prestigious inspections. This accreditation directly talks of the quality par excellence imbibed in every brand of indchemie.
the beta-lactam unit is having several commendable approvals from african regulatory agencies like ethiopia, kenya and malawi. The technical team at beta-lactam facility is now gearing up for other prestigious approvals like mcc south africa and mhra uk.
these approvals will further boost the confidence in our products, who today have high clinical success.
our comprehensive range of products covers wide therapeutic segments wherein a large number of products are technologically backed up with bioequivalence studies at par with brand leaders in the segment.
in ever evolving environs of healthcare industry, keeping pace with the time is a tough task. It requires consistent & qualitative research for which team indchemie is always in the forefront . At indchemie, we are committed to research & development with a vision to create path breaking health solutions, both in chronic as well as acute segments.
in an integral approach to healthcare that fuses traditional wisdom with technological sophistication has made us what we are today, leading to become pioneers in the indian pharma industry. |
Testing Facilities R & Development
Indchemie has strong support and focus on R&D which substantially scaled up on its investments to build its capabilities in all the areas of generic research as a short to medium term strategy. Generic drug development encompasses both small and large molecules. Indchemie strongly believes that there are attractive opportunities in the highly competitive global generic space. Indchemie believes in strategic alliance for R&D and offers its R&D and scale-up facilities to major players for development activities in the Indian Pharma Industry. The business focus is backed with the building up of captive manufacturing operations and of complying with the regulatory standards of the advanced markets. Indchemie's generic drug development meets the speed and quality attributes, as all the elements of research have been conducted within the same campus, situated at Taloja, Navi Mumbai. Indchemie committed a substantial amount of its resources to the development of Novel Drug Delivery Systems and this shall be the key element in providing momentum to consolidate its objective of value addition Indchemie is also collaborating with several Indian companies for their development of difficult-to-make products and the development of other unique technologies. Indchemie is progressing with leaps and bounds in the Nutraceutical segment of healthcare and wellness. Nutraceutical R&D efforts are mainly directed towards providing vitamins and nutritional products for the better management of health in the today’s busy life. Commendable success has been achieved in this area of research and development.
|
 | Fact Sheet | | | Nature of Business | : | Manufacturer, Service Provider, Trader | | Major Markets | : | Indian Subcontinent, East Asia, Middle East, South East Asia and North America |
|
|
Contact Details| | Company Name:
| Indchemie Health Specialities Private Limited | | Contact Person: | Mr. Manager | | Telephone: | +(91)-(22)-30400852 / 30400852
| | Fax No: | +(91)-(22)-30400845 | | Address: | No. 510, Shah & Nahar Industrila Estate, Dr. E. Moses Road, Mumbai, Maharashtra - 400 018 (India) |
|
|
Processing...
